Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves new drug to treat schizophrenia and bipolar disorder

September 17, 2015Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

Post navigation

← Karoun Dairies, Inc. Issues Nationwide Voluntary Recall of Various Cheeses Because of Possible Health Risk Butala Emporium, Inc. Recalls Eleven Ayurvedic Dietary Supplements Because of Elevated Levels of Lead and Mercury →
Proudly powered by WordPress